Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher Scientific (TMO)
NYSE:TMO
TMO Stock Chart & Stats
$618.72
$0.83(0.15%)
At close: 4:00 PM EST
$618.72
$0.83(0.15%)
Day’s Range― - ―
52-Week Range$385.46 - $629.87
Previous CloseN/A
Volume471.20K
Average Volume (3M)1.74M
Market Cap
$234.69B
Enterprise Value$207.75B
Total Cash (Recent Filing)$3.55B
Total Debt (Recent Filing)$35.68B
Price to Earnings (P/E)36.1
Beta0.67
Next Earnings
Jan 29, 2026EPS Estimate
6.45Next Dividend Ex-DateN/A
Dividend Yield0.3%
Share Statistics
EPS (TTM)5.79
Shares Outstanding375,708,070
10 Day Avg. Volume2,596,875
30 Day Avg. Volume1,735,773
Financial Highlights & Ratios
PEG Ratio4.64
Price to Book (P/B)4.01
Price to Sales (P/S)4.63
P/FCF Ratio27.35
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue4.75
Enterprise Value/Gross Profit11.93
Enterprise Value/Ebitda18.33
Forecast
1Y Price Target
$658.89Price Target Upside6.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
EPS Forecast (FY)24.62
Revenue Forecast (FY)$46.58B
Bulls Say, Bears Say
Bulls Say
Acquisition IntegrationAnalyst notes that the Clario acquisition expands Thermo Fisher's clinical trial and endpoint data offerings, enabling cross-selling between CRO and digital services that can improve margins and diversify revenue.
Analytical Instruments MomentumAnalyst points to strong user feedback and recent instrument launches in chromatography, mass spectrometry, and electron microscopy that could drive share gains and higher bookings.
Biopharma And Bioproduction DemandAnalyst highlights accelerating biopharma and bioproduction demand that positions the company to capture market share as biologics manufacturing capacity grows.
Bears Say
AI-related Demand ComparisonsAnalyst warns that tougher year-over-year comparisons in AI-related instrument demand may lead to a segment decline that drags on overall organic growth.
Public Sector Funding WeaknessAnalyst warns that continued pressure in academic and government spending can reduce research-channel sales and weigh on the company's revenue mix.
Trade And Tariff UncertaintyAnalyst cautions that tariff and trade-policy headwinds can erode margin cushions and force downward revisions to earnings guidance.
Thermo Fisher News
TMO FAQ
What was Thermo Fisher Scientific’s price range in the past 12 months?
Thermo Fisher Scientific lowest stock price was $385.46 and its highest was $629.87 in the past 12 months.
What is Thermo Fisher Scientific’s market cap?
Thermo Fisher Scientific’s market cap is $234.69B.
When is Thermo Fisher Scientific’s upcoming earnings report date?
Thermo Fisher Scientific’s upcoming earnings report date is Jan 29, 2026 which is in 10 days.
How were Thermo Fisher Scientific’s earnings last quarter?
Thermo Fisher Scientific released its earnings results on Oct 22, 2025. The company reported $5.79 earnings per share for the quarter, beating the consensus estimate of $5.497 by $0.293.
Is Thermo Fisher Scientific overvalued?
According to Wall Street analysts Thermo Fisher Scientific’s price is currently Undervalued.
Does Thermo Fisher Scientific pay dividends?
Thermo Fisher Scientific pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 0.3%. See more information on Thermo Fisher Scientific dividends here
What is Thermo Fisher Scientific’s EPS estimate?
Thermo Fisher Scientific’s EPS estimate is 6.45.
How many shares outstanding does Thermo Fisher Scientific have?
Thermo Fisher Scientific has 375,708,070 shares outstanding.
What happened to Thermo Fisher Scientific’s price movement after its last earnings report?
Thermo Fisher Scientific reported an EPS of $5.79 in its last earnings report, beating expectations of $5.497. Following the earnings report the stock price went up 1.65%.
Which hedge fund is a major shareholder of Thermo Fisher Scientific?
Currently, no hedge funds are holding shares in TMO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Thermo Fisher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$658.89 (6.49% Upside)
$658.89 (6.49% Upside)
Blogger Sentiment
Bullish
TMO Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 920.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $57.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.53%
12-Months-Change
Fundamentals
Return on Equity
13.14%
Trailing 12-Months
Asset Growth
2.65%
Trailing 12-Months
Company Description
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, growth in key segments, and significant strategic initiatives, including collaborations and acquisitions. However, challenges in the diagnostics sector, particularly in China, and pressures in academic and government sectors were noted.View all TMO earnings summariesTMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
TMO Stock 12 Month Forecast
Average Price Target
$658.89
▲(6.49% Upside)
Technical Analysis
Ownership Overview
0.13% Insiders
23.96% Mutual Funds
0.36% Other Institutional Investors
56.15% Public Companies and Individual Investors